Quality of Reporting of Cancer Prognostic Marker Studies: Association With Reported Prognostic Effect

Abstract

Among cancer prognostic marker studies, reporting quality of design and assay information often appears suboptimal, indicating that this literature may be largely unreliable. Given the potential clinical importance of prognostic marker information, improved design and reporting of these studies are warranted.